Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): A randomized, double-blinded, placebo-controlled parallel multi-center trial
M. G. Fehlings, H. Nakashima, N. Nagoshi, D. S.L. Chow, R. G. Grossman, B. Kopjar
Dive into the research topics of 'Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): A randomized, double-blinded, placebo-controlled parallel multi-center trial'. Together they form a unique fingerprint.